Manager/Sr. Manager, Global Brand Strategy & Corporate Communications

Palo Alto, CA (Hybrid)

$110K/yr – $165K/yrManager5+ years expFull time

Posted 2 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own and implement a global corporate branding and communications program, turning corporate strategy into consistent external messaging, executive readiness, and proactive media narratives.

  • Lead global media relations and executive briefing around clinical, regulatory, conference, and corporate milestones.
  • Coordinate the global narrative calendar and cross-functional branding to ensure a unified voice across channels.
  • Define and apply a dual-brand framework for Innovent and subsidiaries, aligning messaging with strategy milestones.

Job Description

Responsibilities

  • Execute Innovent’s global corporate branding and communications strategy in alignment with corporate strategy, leadership priorities, and oversight from Head of Global Public Relations, ensuring external communications reinforce strategic objectives.
  • Translate corporate strategy into coordinated global messaging, assets, and communications across all external brand channels, ensuring a consistent and unified brand expression.
  • Define, align, and maintain Innovent’s core narrative through close cross-functional partnership, ensuring a consistent brand voice across internal and external communications.
  • Own and maintain the global corporate narrative calendar aligned with corporate strategy milestones, investor communications, and media cycles, ensuring disciplined and timely storytelling across the organization.
  • Build and execute proactive global media narratives aligned with corporate strategy, ensuring timely positioning around key clinical, regulatory, conference, and corporate milestones.
  • Manage and cultivate relationships with tier-1 healthcare, trade and business media to support consistent and credible external visibility for Innovent.
  • Prepare executive spokespersons for media engagements, including message development, briefing materials, and Q&A preparation.
  • Lead Innovent’s corporate brand presence at major global conferences, ensuring consistent visibility across scientific, media, and stakeholder touchpoints (e.g., ASCO, ESMO, AACR).
  • Align conference messaging and execution with corporate strategy and leadership priorities, coordinating executive communications and media engagement.
  • Monitor and analyze external perception of Innovent across media, scientific, investor, and industry audiences, delivering regular insights to leadership on brand positioning effectiveness.

Requirements

  • Bachelor’s degree in Communications, Life Sciences, Business, or a related field preferred
  • Minimum 5-8 years of relevant experience in corporate communications, brand strategy, public relations, or related fields
  • Demonstrated experience translating business or corporate strategy into executed communications, messaging, and brand outputs
  • Prior experience in media relations, including preparing messaging and engaging with external media
  • Excellent written and verbal communication skills, with the ability to develop clear, compelling, and audience-appropriate narratives
  • Strong project management and organizational skills, with the ability to manage multiple priorities and timelines
  • Proven ability to work effectively in cross-functional teams within a fast-paced, collaborative environment
  • Experience managing or coordinating with external partners (e.g., PR agencies, creative agencies)
  • Fluency in business Mandarin (written and spoken)

Preferred

  • Advanced degree (e.g., Master’s) in Communications, Public Relations, Journalism, or a related field
  • Experience in biotech, pharmaceutical, healthcare, or other science-driven industries; candidates from adjacent industries (e.g., technology) with strong communications experience will also be considered
  • Demonstrated ability in scientific or technical writing, including translating complex concepts into accessible messaging
  • Experience working alongside commercial and/or marketing teams, with an understanding of how brand and communications intersect with broader business functions
  • Strong visual and narrative storytelling capabilities, including development of presentations and external-facing materials
  • Experience supporting communications around major milestones (e.g., product launches, data releases, corporate announcements, or large industry events)
  • Familiarity with global communications environments and cross-cultural collaboration
Innovent Biologics logo

Innovent Biologics

3.7 Glassdoor

Established in 2011, Innovent is committed to developing, manufacturing and commercializing high quality innovative medicines for the treatment of major diseases such as cancer. On 31 October, 2018, Innovent was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 01801.HK.Since its inception, Innovent has developed a fully-integrated multi-functional platform which includes R&D, CMC (Chemistry, Manufacturing, and Controls), clinical development and commercialization capabilities. Leveraging the platform, the company has built a robust pipeline of 23 valuable assets in the fields of cancer, metabolic, autoimmune diseases and other major therapeutic areas, with 4 products, TYVYT® (sintilimab injection), BYVASDA® (bevacizumab injection), SULINNO® (adalimumab injection), HALPRYZA® (rituximab injection) officially approved for marketing in China, 5 assets in Phase III or pivotal clinical trials, and additional 14 molecules in to clinical trials. TYVYT® was included in the National Reimbursement Drug List (NRDL) in 2019 as the only PD-1 in that year and was also the first PD-1 inhibitor included in NRDL historically.Innovent has built a biopharmaceutical production facility that operates under global standards. The design and operation of the clinical and commercial facilities are in compliance with the cGMP standards of NMPA, FDA and EMA. The existing production lines have already passed GMP audits by an international pharmaceutical company. Innovent has built an international team of advanced talents in high-end biological drug development and commercialization, including many overseas experts. The company has also entered into strategic cooperation with Eli Lilly, Adimab, Incyte, Hanmi and other international pharmaceutical companies.

Founded in 2011
CHN
848 employees (31 in marketing)
50% recommend to a friend
60% CEO approval

Traffic Signals

Monthly Visitors
20.8K
Traffic Source Mix
Search
45.9%
Direct
44.6%
Referral
5.7%
Social
2.9%
Paid
0.8%

Headcount Trend

Current headcount: ~850

Marketing Team

Marketing Team Size
31 (4% of company)

Funding

Total Funding
$1.5B
Last Raise
$100M
Post IPO Equity, 7 months ago

Funding History

  • Oct 2025
    Post IPO Equity • $100M
  • Jun 2025
    Post IPO Equity • $547.8M
  • Aug 2022
    Post IPO Equity • $308.3M

Recent News